Related Experiment Videos
[The treatment of deep venous thrombosis with low-molecular-weight heparin]
M M Samama1, A Achkar, M H Horellou
1Service d'Hématologie Biologique, Hôtel-Dieu, Paris.
Revue Medicale De Bruxelles
|July 1, 1995
The authors, via a long review of published studies, show that low-molecular weight heparin, with early start of antivitamin K, is actually the treatment of choice in thromboembolic disease.
The authors, via a long review of published studies, show that low-molecular weight heparin, with early start of antivitamin K, is actually the treatment of choice in thromboembolic disease.